Cutaneous reactions to gold salts;Reactions cutanees aux sels d'or

Presse Medicale

Volumn 25, Issue 32, 1996, Pages 1555-1558

  Bonnetblanc, J M ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CORTICOSTEROID; GOLD SALT; HLA B35 ANTIGEN; ANTIRHEUMATIC AGENT; ORGANOGOLD COMPOUND;

ATOPY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG WITHDRAWAL; ECZEMA; HUMAN; LICHENOID ERUPTION; ORAL DRUG ADMINISTRATION; PEMPHIGUS; PITYRIASIS ROSEA; PRURITUS; RASH; REVIEW; RHEUMATOID ARTHRITIS; SKIN MANIFESTATION; STOMATITIS; TASTE DISORDER; ANIMAL; DRUG ERUPTION; IMMUNOLOGY; PATHOPHYSIOLOGY; RISK FACTOR;

ANIMALS; ANTIRHEUMATIC AGENTS; DRUG ERUPTIONS; HUMANS; ORGANOGOLD COMPOUNDS; RISK FACTORS;

EID: 0029949138     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Penneys NS, Ackerman AB, Gottlieb NL. Gold dermatitis: a clinical and histopathological study. Arch Dermatol 1974 ; 109:372-6.
2. Cronstein BN, Weissmann G. The adhesion molecules of inflammation. Arthritis Rheum 1993 ; 36:147-57.
3. Newman PM, To SST, Robinson BG, Hyland VJ, Schrieber L. Effect of gold sodium thiomalate component on the in vitro expression of endothelial cell adhesion molecules. J Clin Invest 1994 ; 94:1864-71.
4. Rudge SR, Perrett D, Kelly M. Failure of oral thiomalate to act as an alternative to intramuscular gold in theumatoid arthritis. Ann Rheum Dis 1988 ; 47:224-7.
5. Svensson A, Theander J. Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate. Ann Rheum Dis 1992 ; 51:326-9.
6. Schuhmann D, Kubicka-Muranyi M, Mirtschewa J, Kind P, Gleichmann E. Adverse immune reactions to gold. Chronic treatment with an Au(I) drug sensitizes mouse spleen cells not to Au(I), but to Au(III) and induces autoantibody formation. J Immunol 1990 ; 145:2132-9.
7. Hashimoto K, Whitehurst CE, Matsubara T, Hirohata K, Lipsky PE. Immunomodulatory effects of therapeutic goid compounds: gold sodium thiomalate inhibits the activity of T cell protein kinase C. J Clin Invest 1992 ; 89:1839-48.
8. Stubb S, Heikkilä H, Kauppinen K. Cutaneous reactions to drugs: a series of in-patients during a five year period. Acta Derm Venerol (Stockh) 1994 ; 74:289-91.
9. Swanbeck G, Dahlberg E. Cutaneous drug reactions. An attempt to quantitative estimation. Arch Dermatol Res 1992 ; 284:215-8.
10. Lockie LM, Smith DM. Forty-seven years experience with gold therapy in 1,019 rheumatoid arthritis patients. Semin Arthritis Rheum 1985 ; 14:238-46.
11. Davis P. Auranofin. Clin Rheum Dis 1984 ; 10:369-83.
12. Kay EA, Jayson MI. Risk factors that may influence development of side effects of gold sodium thiomalate. Scand J Rheumatol 1987 ; 16:241-5.
13. Nüsslein HG, Jahn H, Lösch G, Guggenmoos-Holzmann I, Leibold W, Karden JR. Association of HLA Bw 35 with mucocutaneous lesions in rheumatoid arthritis patients undergoing sodium aurothiomalate therapy. Arthritis Rheum 1984 ; 27:833-6.
14. Gottlieb NL. Metabolism and distribution of gold compounds. J Rheumatol 1979; 6 (Suppl. 5):2-6.
15. Smith RW, Leppard B, Barnett NL, Millward-Sadler GH, McCrae F, Cawley MID. Chrysiasis revisited: a clinical and pathological study. Br J Dermatol 1995 ; 133:671-8.
16. Fleming CJ, Salisbury ELC, Kirwan P, Painter DM, Barnetson RS. Chrysiasis after low-dose and UV light exposure. J Am Acard Dermatol 1996 ; 34:349-51.
17. Trotter MJ, Tron VA, Hollingdale J, Rivers JK. Localized chrysiasis induced by laser therapy. Arch Dermatol 1995 ; 131:1411-14.
18. Keen CE, Brady K, Kirkham N, Levison DA. Gold in the dermis following chrysotherapy: histopathology and microanalysis. Histopathology 1993 ; 23:355-60.
19. Ikezawa Z, Kitamura K, Nakajima H. Gold sodium thiomalate (GTM) induces hypersensitivity to thiomalate, the thiol carrier of GTM. J Dermatol 1990 ; 17:550-4.
20. Zürcher K, Krebs A. Cutaneous drug reactions. Karger, Basel 1992 :260-1.
21. Lizeau-Parneix V, Bedane C, Lavignac C, Bernard P, Bonnetblanc JM. Réactions cutanées aux sels d'or. Ann Dermatol Venereol 1994 ; 121:793-7.
22. Wilkinson SM, Smith AG, Davis MJ, Mattey D, Dawes PT. Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold. Ann Rheum Dis 1992 ; 51:881-4.
23. Bonnetblanc JM. Drug hypersensitivity syndrome. Dermatology 1993 ; 187:84-5.
24. Wilkinson SM, Smith AG. Gold toxicity presenting as a mucosal lichenoid eruption. J Dermatol Treat 1990 ; 1:261-2.
25. Möller H, Larsson A, Björkner B, Bruze M, Hagstam A. Flare-up at contact allergy sites in a gold-treated rheumatic patient. Acta Derm Venereol (Stockh) 1996 ; 76:55-8.
26. Tumiati B, Veneziani M, Belleli A, Portioli I. Muccocutaneous toxicity of gold salts by parenteral administration. Rechallenge with auranofin. J Rheumatol 1987 ; 14:177.
27. Goldermann R, Schuppe HC, Gleichmann E et al. Adverse immune reactions to gold in rheumatoid arthritis: lack of skin reactivity. Acta Derm Venereol (Stockh) 1993 ; 73:220-2.